The Report

Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses

10 reports and counting

Updated daily with latest market intelligence
Fundraising
Omega

Omega Raises $3B in Private

Omega, a Watches company based in Jakob-Stämpfli-Strasse 96, Biel/Bienne 2502, Switzerland, has raised $3B in Private at a $4B valuation led by Swatch Group.

Fundraising News Team
Jan 1, 2024
0 min read
Watches
Omega

Omega raises $3B Private at $4B valuation

Omega raises $3B in Private at $4B valuation. Swiss luxury watchmaker...

Editorial Team
Jan 1, 2024
0 min read$3B
Fundraising
Omega Healthcare Investors

Omega Healthcare Investors Raises $15B in Public

Omega Healthcare Investors, a Real Estate company based in 303 International Circle, Hunt Valley, MD 21030, has raised $15B in Public at a $16B valuation led by Public.

Fundraising News Team
Jan 1, 2024
0 min read
Real Estate
Omega Healthcare Investors

Omega Healthcare Investors raises $15B Public at $16B valuation

Omega Healthcare Investors raises $15B in Public at $16B valuation. Healthcare REIT...

Editorial Team
Jan 1, 2024
0 min read$15B
Fundraising
Artbio

Artbio Raises $132M in Series B

Artbio, a Biotech company based in Cambridge, MA, has raised $132M in Series B at a $700M valuation led by Novo Holdings, Omega Funds.

Fundraising News Team
Feb 8, 2025
0 min read
Fundraising
Beam Therapeutics

Beam Therapeutics Raises $206M in Series C

Beam Therapeutics, a Biotech company based in 238 Main Street, Cambridge, MA 02142, has raised $206M in Series C at a $3.5B valuation led by Foresite Capital, F-Prime Capital, Omega Funds, Redmile Group, Wellington Management.

Fundraising News Team
May 3, 2024
0 min read
Fundraising
Annexon Biosciences

Annexon Biosciences Raises $125M in Series D

Annexon Biosciences, a Biotech company based in 180 Kimball Way, South San Francisco, CA 94080, has raised $125M in Series D at a $750M valuation led by GV, Alta Partners, Omega Funds, Cowen Healthcare Investments, Redmile Group.

Fundraising News Team
Aug 18, 2024
0 min read
Biotech
Annexon Biosciences

Annexon Biosciences raises $125M Series D at $750M valuation

Annexon Biosciences raises $125M in Series D at $750M valuation. Classical complement pathway inhibitors...

Editorial Team
Aug 18, 2024
0 min read$125M
Biotech
Beam Therapeutics

Beam Therapeutics raises $206M Series C at $3.5B valuation

Beam Therapeutics raises $206M in Series C at $3.5B valuation. Base editing technology...

Editorial Team
May 3, 2024
0 min read$206M
Page 1

Showing 9 reports • Page 1 • Category: all

Stay ahead of the market

Get weekly insights delivered to your inbox. No spam, just intelligence.